Cancer Prevention and Research Institute of Texas - Recruitment or Retention of Clinical Trialists Award - RFA R-27.2-RRCTA (2026)
Cancer Prevention and Research Institute of Texas | State of TexasState · Austin, TX- Due
- Nov 18, 2026
- 11 days left
- Posted
- Aug 5, 2026
- Contract term
- 5 years
The 30-second brief
The Cancer Prevention and Research Institute of Texas (CPRIT) is issuing Request for Applications RFA R-27.2-RRCTA to provide support to recruit and retain physicians running clinical trials, such as oncologists, to lead cancer therapeutic clinical trials programs in rural and/or underserved communities in Texas. The award provides grant funding ranging from $2,000,000 to $3,000,000 for a 5-year contract term to support salary, fringe, essential clinical trials staff like research nurses or regulatory managers, and start-up costs. Applications must be submitted online via the new CPRIT Grants Management Platform (GMP) portal. The submission deadline for cycle 27.1 is November 18, 2026, with subsequent application receipt dates on March 22, 2027, and May 20, 2027. Eligible applicants include Texas public or non-profit organizations, health care systems, or community hospitals.
Quality of the PI and potential for continued superb performance, Strength of institutional commitment, Scientific Merit and Feasibility of Proposed Research, Relevance of PI's Research, Research Environment
Bids like this start as pre-RFPs. Get the next ones early.
Get matched pre-RFPs freeFree account · 30-second setup · No credit card
Summary
The Cancer Prevention and Research Institute of Texas (CPRIT) is issuing Request for Applications RFA R-27.2-RRCTA to provide support to recruit and retain physicians running clinical trials, such as oncologists, to lead cancer therapeutic clinical trials programs in rural and/or underserved communities in Texas.
The award provides grant funding ranging from $2,000,000 to $3,000,000 for a 5-year contract term to support salary, fringe, essential clinical trials staff like research nurses or regulatory managers, and start-up costs. Applications must be submitted online via the new CPRIT Grants Management Platform (GMP) portal. The submission deadline for cycle 27.1 is November 18, 2026, with subsequent application receipt dates on March 22, 2027, and May 20, 2027. Eligible applicants include Texas public or non-profit organizations, health care systems, or community hospitals.
EVALUATION CRITERIA
5- Quality of the PI and potential for continued superb performance
- Strength of institutional commitment
- Scientific Merit and Feasibility of Proposed Research
- Relevance of PI's Research
- Research Environment
- Submit to
- https://gmp.cprit.texas.gov
- Scope location
- Austin, TX
- Reported agency
- Cancer Prevention and Research Institute of Texas
Questions about this RFEI
How do I respond to this RFEI from Cancer Prevention and Research Institute of Texas | State of Texas?
Review the full solicitation document for submission requirements, evaluation criteria, and deadlines. The submission deadline is November 18, 2026. Submissions should be delivered to: https://gmp.cprit.texas.gov.
Can small businesses or minority-owned firms bid on this RFEI?
Most government agencies, including Cancer Prevention and Research Institute of Texas | State of Texas in TX, encourage participation from small businesses, minority-owned, women-owned, and disadvantaged business enterprises (MBE/WBE/DBE). Check the full solicitation for any small business participation goals.
What happens after the RFEI submission deadline?
After the deadline, the issuing agency reviews all submissions against the stated evaluation criteria. This typically includes a compliance check, technical evaluation, cost analysis, and may involve oral presentations with shortlisted vendors.
Show 6 more questions
What are the evaluation criteria for this solicitation?
This solicitation includes specific evaluation criteria that will be used to score proposals. The criteria include: "Quality of the PI and potential for continued superb performance, Strength of institutional commitment, Scientific Merit and Feasibility of Proposed Research, Relevance of PI's Research, Research Envi..." Vendors should carefully align their proposals with each criterion to maximize their score.
Where can I find more RFPs from Cancer Prevention and Research Institute of Texas | State of Texas?
All active and historical solicitations from Cancer Prevention and Research Institute of Texas | State of Texas are tracked and searchable. As a state agency, Cancer Prevention and Research Institute of Texas | State of Texas regularly publishes solicitations. Visit the agency profile to see current open bids, past contracts, vendor relationships, and decision-maker contacts.
What is the contract term for this solicitation?
The anticipated contract term is 5 years. Contract terms may include renewal options.
Is this solicitation still open for submissions?
Based on the posted deadline of November 18, 2026, this solicitation appears to still be accepting submissions. Deadlines may change through amendments or addenda, so always verify the current status directly with the issuing agency before preparing your response.
What documents are required to bid on this RFEI?
Requirements vary by solicitation, but common documents include a technical proposal, cost/price proposal, proof of insurance, relevant certifications, past performance references, and any forms specified in the solicitation. Review the full document from Cancer Prevention and Research Institute of Texas | State of Texas for the complete list.
What is the scope of this project?
This solicitation defines a specific project scope. The scope covers the following locations: Austin, TX. Review the full solicitation for detailed scope requirements.